BRIEF-Kestra Medical Technologies Inc Q2 EPS USD -0.64
Dec 11 (Reuters) - Kestra Medical Technologies Inc Q2 revenue USD 22.565 million vs. IBES estimate USD 20.7 million.
- Q2 gross profit USD 11.424 million
- Q2 adjusted EBITDA USD -19.682 million vs. IBES estimate USD -20.6 million
- Q2 income from operations USD -31.755 million
- outlook FY revenue USD 91 million
- outlook FY revenue growth 52%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments